| abstract |
FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions refers to a compound of formula (I) or its pharmaceutically acceptable salts of formula (I), wherein X represents O, S; Y represents O, S; Rindependently represents H, alkyl; Grepresents ethyl; each Gand Gare independently specified in H, alkyl, trifluoromethyl, halogen, nitro, amido, cyano and tetrazolyl. The invention also refers to a pharmaceutical composition possessing activating action on peroxisome proliferator activated receptors subtype ?, subtype ? and subtype ? and containing an effective amount of the compound of formula (I) or its pharmaceutically acceptable salts. The compounds of formula (I) are applicable for treating or producing a drug preparation for treating or preventing the diseases associated with peroxisome proliferator activated receptors subtype ?, subtype ? and subtype ?. The compounds of formula (I) are produced by a reaction of the compound of formula (III) and the compound of formula (IV) when heated in acetonitrile under reflux in the presence of potassium carbonate to produce the compound of formula (II), to saponify the compound of formula (II) in alcoholic solution in the presence of alkali and to acidify the reaction mixture to produce the compound of formula (I). X, Y, R, G, Gand Ghave the above values; Rrepresents a leaving group specified in OH, Cl, Br, I, OTs, OMs.EFFECT: compounds of phenylpropionic acid possessing the activating action on peroxisome proliferator activated receptors (PPAR?, ?, ?).15 cl, 2 ex |